Discover how ONGLYZA helps reduce blood glucose by prolonging GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) incretin activity in a glucose-dependent manner.
Eating increases levels of glucose in the body.
In response to increased levels of glucose, the small intestine increases production and release of GLP-1 and GIP incretins into the bloodstream. These hormones contribute to glucose homeostasis.1
Eating increases levels of glucose in the body.
In response to increased levels of glucose, the small intestine increases production and release of GLP-1 and GIP incretins into the bloodstream. These hormones contribute to glucose homeostasis.1
The enzyme dipeptidyl peptidase-4 (DPP-4) begins degrading the GLP-1 and GIP incretins within minutes of their release. Consequently, GLP-1 and GIP are short-lived, disrupting glucose homeostasis.1
The enzyme dipeptidyl peptidase-4 (DPP-4) begins degrading the GLP-1 and GIP incretins within minutes of their release. Consequently, GLP-1 and GIP are short-lived, disrupting glucose homeostasis.1
ONGLYZA is a DPP-4 inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.1
ONGLYZA inhibits DPP-4 enzymes for a 24-hour period, thereby prolonging the body’s own action of naturally secreted incretins GLP-1 and GIP.1
ONGLYZA is a DPP-4 inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.1
ONGLYZA inhibits DPP-4 enzymes for a 24-hour period, thereby prolonging the body’s own action of naturally secreted incretins GLP-1 and GIP.1
4 HOW ONGLYZA MAY HELP TO LOWER A1C LEVELS
GLP-1 signals to the pancreas to decrease glucagon secretion by pancreatic alpha cells, which decreases hepatic glucose productions.1
GLP-1 and GIP increase insulin release by signaling the pancreatic beta cells, which increase uptake of glucose by the muscle, fat, and peripheral tissues.1
By inhibiting DPP-4, ONGLYZA helps to reduce fasting plasma glucose (FPG), and postprandial glucose (PPG) in a glucose-dependent manner, which helps to reduce blood glucose levels and A1C.1
A TREATMENT FOR ADULTS WITH TYPE 2 DIABETES MELLITUS, IN ADDITION TO DIET AND EXERCISE
Consider ONGLYZA as an add-on to commonly used oral agents such as metformin to help your patients get to where they need to be.1